• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    12/15/23 12:46:24 PM ET
    $AADI
    $ALRN
    $ATAK
    $ATNI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AADI alert in real time by email

    Shares of Quanex Building Products Corporation (NYSE:NX) moved lower during Friday’s session after the company reported fourth-quarter financial results.

    Quanex Building Products shares fell 10.7% to $30.95 on Friday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Getaround, Inc. (NYSE:GETR) shares climbed 128.3% to $0.3767 after the company reported a year-over-year increase in third-quarter financial results.
    • Battalion Oil Corporation (NYSE:BATL) gained 81.4% to $9.57 after the company announced it will be acquired by Fury Resources.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) shares climbed 61.7% to $0.2749 after the company and Arrive Technology announced an agreement and plan of merger.
    • Brilliant Acquisition Corporation (NASDAQ:BRLI) shares gained 60.2% to $10.25.
    • Elevai Labs, Inc. (NASDAQ:ELAB) gained 32.4% to $2.41.
    • NCS Multistage Holdings, Inc. (NASDAQ:NCSM) rose 31.7% to $18.49. NCS Multistage Holdings said that its subsidiary has settled outstanding litigation with Boyd & McWilliams.
    • iCoreConnect Inc. (NASDAQ:ICCT) surged 31.6% to $1.29.
    • Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) gained 27% to $4.7764. Verrica Pharmaceuticals' development and commercialization partner Torii Pharmaceutical revealed positive top-line results from confirmatory Phase 3 trial of TO-208 for the treatment of molluscum contagiosum in Japan.
    • loanDepot, Inc. (NYSE:LDI) gained 23% to $3.3134.
    • Netcapital Inc. (NASDAQ:NCPL) shares rose 21.2% to $0.42 following second-quarter results.
    • La Rosa Holdings Corp. (NASDAQ:LRHC) gained 20% to $1.8001. La Rosa Holdings acquired a 100% interest in the company’s franchisee - La Rosa Realty CW Properties in Longwood, Florida.
    • Genius Group Limited (NYSE:GNS) rose 19% to $0.7025. Genius Group expects full year 2023 revenue in the range of $27 million-$29 million.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) rose 18.2% to $0.1791 after falling 35% on Thursday.
    • Near Intelligence, Inc. (NASDAQ:NIR) gained 16.3% to $0.0857 after gaining over 5% on Thursday.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) gained 13.8% to $0.1791 following second-quarter results.
    • ATN International, Inc. (NASDAQ:ATNI) rose 13.1% to $38.12. ATN International Board of Directors expanded share repurchase program to $25 million and increased dividend from $0.21 to $0.24 per share.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) surged 10.4% to $9.02.
    • Context Therapeutics Inc. (NASDAQ:CNTX) gained 9.5% to $1.03.

    Losers

    • Chanson International Holding (NASDAQ:CHSN) fell 78% to $3.24.
    • Inno Holdings Inc. (NASDAQ:INHD) shares fell 72.8% to $3.78 after jumping over 246% on Thursday. The company priced its IPO at $4 per share.
    • Aadi Bioscience, Inc. (NASDAQ:AADI) shares fell 56.4% to $2.3450 after the company reported interim results from the PRECISION1 trial of nab-sirolimus.
    • Mangoceuticals, Inc. (NASDAQ:MGRX) fell 40.4% to $0.3101 after declining around 10% on Thursday.
    • Northann Corp. (NYSE:NCL) fell 40.4% to $6.68.
    • Aileron Therapeutics, Inc. (NASDAQ:ALRN) shares fell 38% to $3.33 after jumping 115% on Thursday.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) fell 35.8% to $1.0784 after the company reported pricing of $50 million public offering.
    • Aurora Technology Acquisition Corp. (NASDAQ:ATAK) fell 26.7% to $7.70.
    • Cingulate Inc. (NASDAQ:CING) fell 25.5% to $2.1522. On Dec 13, Cingulate's Louis G. Van Horn, Chief Financial Officer, retired from the company.
    • Freight Technologies, Inc. (NASDAQ:FRGT) fell 25% to $0.45. Freight Technologies shares jumped 122% on Thursday after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) dipped 16% to $6.00.
    • Scholastic Corporation (NASDAQ:SCHL) fell 11.8% to $36.59 after the company posted weaker-than-expected results for its second quarter. The company’s board also approved an additional $66 million for share repurchases.
    • New York Mortgage Trust, Inc. (NASDAQ:NYMT) declined 11.5% to $8.48.
    • Indivior PLC (NASDAQ:INDV) fell 9.6% to $14.81.
    • Genelux Corporation (NASDAQ:GNLX) fell 9.3% to $13.43.
    • SomaLogic, Inc. (NASDAQ:SLGC) fell 9% to $2.1910. Nautilus Biotechnology filed suit in US District Court against SomaLogic and California Institute of Technology seeking declaratory judgment that the company does not infringe any claims of US Patent No. 7,842,793 related to DNA origami structures.
    • Hovnanian Enterprises, Inc. (NYSE:HOV) declined 7% to $149.76.

    Now Read This: Bitcoin Falls Below This Key Level; KuCoin Token, BitTorrent Among Top Losers

    Get the next $AADI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AADI
    $ALRN
    $ATAK
    $ATNI

    CompanyDatePrice TargetRatingAnalyst
    Scholastic Corporation
    $SCHL
    3/9/2026Buy → Neutral
    B. Riley Securities
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Eos Energy Enterprises Inc.
    $EOSE
    12/17/2025$16.00Neutral
    Analyst
    Genelux Corporation
    $GNLX
    10/21/2025$16.00Buy
    Lake Street
    Context Therapeutics Inc.
    $CNTX
    9/18/2025$5.00Buy
    Guggenheim
    Eos Energy Enterprises Inc.
    $EOSE
    9/5/2025$6.50Hold
    Jefferies
    Scholastic Corporation
    $SCHL
    9/3/2025$37.00Buy
    B. Riley Securities
    loanDepot Inc.
    $LDI
    8/19/2025Neutral
    BTIG Research
    More analyst ratings

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering

    RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 0.625% convertible senior notes due 2031 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previously announced offering size of $400,000,000 aggregate principal amount of notes. Indivior also granted the initial purchasers of the notes a 30-day option to purchase up to an additional $50,000,000 principal amount of notes. The sale o

    3/12/26 8:30:00 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 12, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the expansion of its proprietary AI Signature Agent platform through the curation of a rare disease signature database. Sarborg announced that it has curated a database containing approximately 1,700 rare disease signatures, building upon its existing disease signature library of more than 1,600 conditions, as well as its agrochemical and bacterial signature datasets previously announced. According to Sarborg, structuring rare diseases as machine-interpretable biological signatures enables rapid an

    3/12/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Indivior Announces Proposed Convertible Senior Notes Offering

    RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due 2031 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Indivior also expects to grant the initial purchasers of the notes a 30-day option to purchase up to an additional $60,000,000 principal amount of notes. The notes will be senior, unsecured obligations of Indivior, will accrue interest payable semi-a

    3/12/26 7:00:00 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and CSO Silva Raul R. was granted 4,526 shares and covered exercise/tax liability with 1,828 shares, increasing direct ownership by 139% to 4,645 units (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    3/11/26 8:13:31 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, CLO and CCO Patel Nilay Dahyabhai was granted 5,475 shares and covered exercise/tax liability with 2,086 shares (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    3/11/26 8:13:27 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Schaffer Shane J. was granted 6,862 shares and covered exercise/tax liability with 2,959 shares, increasing direct ownership by 2,256% to 4,076 units (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    3/11/26 8:13:30 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ALRN
    $ATAK
    $ATNI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for YCANTH issued to VERRICA PHARMACEUTICALS INC

    Submission status for VERRICA PHARMACEUTICALS INC's drug YCANTH (ORIG-1) with active ingredient CANTHARIDIN has changed to 'Approval' on 07/21/2023. Application Category: NDA, Application Number: 212905, Application Classification: Type 5 - New Formulation or New Manufacturer

    7/21/23 4:54:32 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Scholastic Corp downgraded by B. Riley Securities

    B. Riley Securities downgraded Scholastic Corp from Buy to Neutral

    3/9/26 8:09:51 AM ET
    $SCHL
    Books
    Consumer Discretionary

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Analyst initiated coverage on Eos Energy with a new price target

    Analyst initiated coverage of Eos Energy with a rating of Neutral and set a new price target of $16.00

    12/17/25 9:19:09 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kingsley Stuart A bought $29,953 worth of shares (940 units at $31.86), increasing direct ownership by 20% to 5,582 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 9:54:36 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ryan Barbara bought $1,009 worth of shares (31 units at $32.56), increasing direct ownership by 0.55% to 5,716 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 8:12:31 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Urban David bought $100,100 worth of shares (16,250 units at $6.16), increasing direct ownership by 35% to 62,471 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/10/26 8:52:43 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $AADI
    $ALRN
    $ATAK
    $ATNI
    SEC Filings

    View All

    Context Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - Context Therapeutics Inc. (0001842952) (Filer)

    3/13/26 4:09:24 PM ET
    $CNTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Battalion Oil Corporation

    8-K - BATTALION OIL CORP (0001282648) (Filer)

    3/13/26 6:00:36 AM ET
    $BATL
    Oil & Gas Production
    Energy

    SEC Form 10-K filed by loanDepot Inc.

    10-K - loanDepot, Inc. (0001831631) (Filer)

    3/12/26 4:53:44 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Leadership Updates

    Live Leadership Updates

    View All

    Alaska Communications Strengthens Carrier & Wholesale Services with New Leadership

    Alaska Communications is enhancing its carrier and wholesale services organization to deliver greater value for partners and customers with the appointment of Jesse Kleinbach as the new vice president of the organization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260119649040/en/Pictured: Jesse Kleinbach. With more than 25 years in telecom, Kleinbach brings expertise in creating solutions that help partners succeed. He has led initiatives that simplify connectivity, expand market opportunities, and ensure customers receive reliable, innovative services. In his new role, Kleinbach will focus on expanding service options, i

    1/19/26 11:00:00 AM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications

    Scholastic Appoints Jeffrey Mathews as President of Scholastic Education, Adding to Current Role as Chief Growth Officer

    NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Scholastic Corporation (NASDAQ:SCHL), the global children's publishing, education and media company, today announced that Jeffrey Mathews has been appointed President, Scholastic Education, effective immediately, in addition to his current role as Executive Vice President and Chief Growth Officer. Based in New York, Mr. Mathews continues to report to Peter Warwick, Scholastic President and Chief Executive Officer. Scholastic Education advances Scholastic's mission by helping schools and educators address one of their most critical needs –

    1/5/26 9:30:00 AM ET
    $SCHL
    Books
    Consumer Discretionary

    Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

    WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) --  Genelux Corporation (NASDAQ:GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Jason Litten, M.D., as Chief Medical Officer, effective January 2, 2026. Dr. Litten will oversee all clinical development and medical strategy as the company advances Olvi-Vec through multiple upcoming pivotal milestones. "We are excited to welcome Jason, who is widely recognized for his strategic approach to clinical development and commitment to improving patient outcomes," said Thomas Zindrick, President, CEO, and Chairman of the Board. "He brings extensive experience in oncology drug development of innovati

    1/2/26 8:00:00 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Financials

    Live finance-specific insights

    View All

    loanDepot Announces Year-End and Fourth Quarter 2025 Financial Results

    Delivered highest quarterly loan origination volume since 2022. Grew market share 19% while investing in digital infrastructure to scale for growth. Full-year 2025 highlights: Revenue increased 12% to $1.19 billion and adjusted revenue increased 10% to $1.21 billion compared to the prior quarter on higher pull-though weighted lock volume and margin. Pull-through weighted gain on sale margin increased 19 basis points to 336 basis points. Expenses increased 1% to $1.31 billion, reflecting discipline in driving operating efficiencies. Net loss of $108 million was down 47%, compared with net loss of $202 million in the prior year, primarily a result of higher revenue. Adjuste

    3/10/26 4:06:00 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    ZIM Reports Financial Results for the Fourth Quarter and the Full Year of 2025

    Reported Full Year Revenues of $6.90 Billion, Net Income of $481 Million1, Adjusted EBITDA2 of $2.17 Billion and Adjusted EBIT2 of $885 Million3Generated Full Year Adjusted EBITDA and Adjusted EBIT Margins2 of 31% and 13%, Respectively Declared Q4 2025 Dividend of Approximately $106 Million, or $0.88 per Share, Representing, Together with Previous Dividends Distributed on Account of 2025 Results, Approximately 50% of the Full Year 2025 Net Income Dividends to Total Approximately $5.8 Billion Over Last Five Years—More Than 25 Times the Amount Raised at IPO in January 2021HAIFA, Israel, March 9, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ("ZIM" or the "Company"), a g

    3/9/26 7:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    Quanex Building Products Announces First Quarter 2026 Results and Provides Full Year 2026 Guidance

    Net Sales Growth of ~2% Year-Over-YearHealthy Balance Sheet and Strong LiquidityWell Positioned to Capitalize on Pent-Up Demand HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) ("Quanex" or the "Company") today announced its results for the three months ended January 31, 2026.   The Company reported the following selected financial results:  Three Months Ended January 31,($ in millions, except per share data)2026 2025Net Sales$409.1 $400.0Gross Margin$98.5 $92.3Gross Margin %24.1% 23.1%Net Loss($4.1) ($14.9)Diluted EPS($0.09) ($0.32)    Adjusted Net (Loss) Income($0.3) $9.0Adjusted Diluted EPS($0.01) $0.19Adjusted EBITDA$27.4 $38.5Adjusted EBITDA

    3/5/26 4:15:00 PM ET
    $NX
    Metal Fabrications
    Industrials

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Verrica Pharmaceuticals Inc.

    SC 13G/A - Verrica Pharmaceuticals Inc. (0001660334) (Subject)

    12/9/24 6:22:49 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ALRN
    $ATAK
    $ATNI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Air Transport Services Group Inc on Jun 7 Indicate?

    Recently, on June 7, 2024, Michael L Berger, a significant figure at Air Transport Services Group Inc, made a notable insider purchase. Berger bought $49,830 worth of shares, acquiring 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units as reported in the SEC Form 4 here. Examining other insider actions within the company can sometimes reveal intriguing patterns that might offer insights for investors. Looking back at previous transactions, we see a series of insider activities at Air Transport Services Group Inc: In March 2024, Dominick Jeffrey A. filed an SEC Form 4, indicating a notable transaction date in which actions were

    6/10/24 12:35:45 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care